ARCHIVES

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

NCI Plans to Fund FY 1985 R01s, P01s with Cuts 2.9-3.8% Under Recommended Groups, Centers Reduced 7-10%

March 16, 1984

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995